Assignee
INIVATA LTD
GB·19 granted patents·15 pending applications·25 citations·filing 2017–2025
Top patents by PatentIndex Score
34 records- 0191US10329627B1Method for predicting and monitoring response to an immune checkpoint inhibitorINIVATA LTD·Filed 2018·Granted Jun 25, 2019·9 cites·11 claims
- 0290US11186878B2Method for predicting and monitoring response to an immune checkpoint inhibitorINIVATA LTD·Filed 2019·Granted Nov 30, 2021·6 cites·12 claims
- 0386US12371744B2Method of sequencing a nucleic acid of interestINIVATA LTD·Filed 2024·Granted Jul 29, 2025·0 cites·28 claims
- 0485US11168371B2Computational method for detecting fusion eventsINIVATA LTD·Filed 2019·Granted Nov 9, 2021·2 cites·12 claims
- 0585US10876170B2Method for detecting a genomic rearrangement involving the ALK gene in cell-free DNAINIVATA LTD·Filed 2018·Granted Dec 29, 2020·2 cites·7 claims
- 0684US11359233B2Methods for labelling nucleic acidsINIVATA LTD·Filed 2017·Granted Jun 14, 2022·2 cites·15 claims
- 0784US2025340926A1Variable replicate multiplex pcrINIVATA LTD·Filed 2025·Application pending·0 cites
- 0883US10533214B2Method for measuring mutational loadINIVATA LTD·Filed 2018·Granted Jan 14, 2020·3 cites·8 claims
- 0983US2025051841A1Methods of labelling nucleic acidsINIVATA LTD·Filed 2024·Application pending·0 cites
- 1081US12365940B2Methods of labelling nucleic acids using variable length oligonucleotidesINIVATA LTD·Filed 2023·Granted Jul 22, 2025·0 cites·20 claims
- 1181US11788116B2Method for the analysis of minimal residual diseaseINIVATA LTD·Filed 2023·Granted Oct 17, 2023·0 cites·24 claims
- 1280US11377698B2Method of treating a cancer patient without the need for a tissue biopsyINIVATA LTD·Filed 2019·Granted Jul 5, 2022·1 cites·10 claims
- 1380US2025188547A1Method of treating a cancer patient without the need for a tissue biopsyINIVATA LTD·Filed 2024·Application pending·0 cites
- 1477US12378595B2Method for the analysis of minimal residual diseaseINIVATA LTD·Filed 2023·Granted Aug 5, 2025·0 cites·20 claims
- 1576US2025146064A1Methods of sequencing nucleic acids and error correction of sequence readsINIVATA LTD·Filed 2024·Application pending·0 cites
- 1675US2025037792A1Computational assessment of genetic variant qualityINIVATA LTD·Filed 2024·Application pending·0 cites
- 1774US12195807B2Method of treating a cancer patient without the need for a tissue biopsyINIVATA LTD·Filed 2022·Granted Jan 14, 2025·0 cites·8 claims
- 1874US12084724B2Computational method for detecting fusion eventsINIVATA LTD·Filed 2021·Granted Sep 10, 2024·0 cites·16 claims
- 1972US12516370B2Methods for labelling nucleic acidsINIVATA LTD·Filed 2022·Granted Jan 6, 2026·0 cites·8 claims
- 2072US11674175B2Methods of labelling nucleic acidsINIVATA LTD·Filed 2019·Granted Jun 13, 2023·0 cites·22 claims
- 2170US2025378907A1Cancer-associated genetic variant filtering using mutational signaturesINIVATA LTD·Filed 2025·Application pending·0 cites
- 2269US2024425930A1Methods for selective sequencing of cancer dnaINIVATA LTD·Filed 2024·Application pending·0 cites
- 2368US11566274B2Method for the analysis of minimal residual diseaseINIVATA LTD·Filed 2020·Granted Jan 31, 2023·0 cites·20 claims
- 2467US2021139996A1Method for detecting genomic rearrangementsINIVATA LTD·Filed 2020·Application pending·0 cites
- 2566US12163187B2Methods of sequencing nucleic acids and error correction of sequence readsINIVATA LTD·Filed 2019·Granted Dec 10, 2024·0 cites·16 claims
- 2665US2025273296A1Method of detecting cancer dna in a sampleINIVATA LTD·Filed 2023·Application pending·0 cites
- 2764US2024132965A1Highly sensitive method for detecting cancer dna in a sampleINIVATA LTD·Filed 2023·Application pending·0 cites
- 2855US12247249B2Method for amplifying a genomic sampleINIVATA LTD·Filed 2019·Granted Mar 11, 2025·0 cites·15 claims
- 2951US2022017970A1Method for quantifying gene fusion dnaINIVATA LTD·Filed 2019·Application pending·0 cites
- 3050US12509733B1Methods and systems for detecting a primary diseaseINIVATA LTD·Filed 2025·Granted Dec 30, 2025·0 cites·30 claims
- 3149US2023304084A1Method for quantifying the amount of a target sequence in a sampleINIVATA LTD·Filed 2020·Application pending·0 cites
- 3246US2025270629A1Method for amplifying a genomic sampleINIVATA LTD·Filed 2025·Application pending·0 cites
- 3346US2022325356A1METHOD FOR ALTERING THERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS BASED ON ANALYSIS OF ctDNAINIVATA LTD·Filed 2020·Application pending·0 cites
- 3444US2021040564A1Method for predicting and monitoring response to an immune checkpoint inhibitorINIVATA LTD·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →